SCHEMBL235492

SCHEMBL235492

C=C(C)C(=O)ON

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29197869 1.00 ALDH1A1 (0.55)
SCHEMBL28453190 0.97
Hydrochloric Acid SCHEMBL23406869 0.97
SCHEMBL23406868 0.97
Fluoride SCHEMBL31173609 0.97
SCHEMBL25273340 0.97
Bromide SCHEMBL502249 0.97
Methacrylic Acid SCHEMBL4887475 0.92 ALDH1A1 (0.48)
Methacrylic Acid SCHEMBL28921732 0.92 ALDH1A1 (0.48)
Benzene SCHEMBL27783118 0.92 ALDH1A1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3575 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260130859-A1 PALATABLE FORMULATIONS ELANCO US INC (US) 2026-05-14 US claimed
EP-4687851-A1 SOLID ORAL DOSAGE FORM COMPRISING ANTIBODIES FOR SUSTAINED RELEASE IN THE LOWER GASTROINTESTINAL TRACT TILLOTTS PHARMA AG (CH) 2026-02-11 EP claimed
US-12544336-B2 Palatable formulations ELANCO US INC. 2026-02-10 US claimed
US-20260015522-A1 EPOXY CURED POLYURETHANES AND ADDITIVE MANUFACTURING METHODS USING SAME CARBON INC (US) 2026-01-15 US claimed
EP-3873394-B1 SYSTEM FOR ANALYSIS OF BODY FLUIDS AND WOUND-ASSOCIATED BIOMOLECULES PROGENITEC INC (US) 2025-12-24 EP claimed
EP-4661830-A1 COMPOSITION AND METHOD FOR TOOTH WHITENING WITH SENSITIVITY RELIEF Koninklijke Philips N.V. (NL) 2025-12-17 EP claimed
US-12486478-B2 Consumer products comprising delivery particles with high core:wall ratios THE PROCTER & GAMBLE COMPANY (US) 2025-12-02 US claimed
US-20250352537-A1 PHARMACEUTICAL COMPOSITIONS OF TRICYCLIC AKR1C3 DEPENDENT KARS INHIBITOR AND METHODS FOR MAKING SAME NOVARTIS AG (CH) 2025-11-20 US claimed
US-20250186435-A1 PHARMACEUTICAL FORMULATIONS AND THEIR PREPARATIONS FOR TREATMENT OF CANCER CELLIX BIO PRIVATE LIMITED (IN) 2025-06-12 US claimed
CN-119912627-A Preparation method of viscosity index improver of automatic gearbox oil 新乡市瑞丰新材料股份有限公司 2025-05-02 CN claimed
EP-0207569-B1 PROCESS FOR COATING AN ELECTRICALLY CONDUCTIVE SUBSTRATE AND AN AQUEOUS COATING COMPOSITION BASED ON A CATIONIC BINDER AKZO N.V. (NL) 1988-11-17 EP claimed
US-4661223-A BINDER OBTAINED BY POLYMERIZATION IN PRESENCE OF ETHYLENICALLY UNSATURATED POLYESTER AKZO NV (NL) 1987-04-28 US claimed
EP-0104683-B1 PROCESS FOR COATING AN ELECTRICALLY CONDUCTIVE SUBSTRATE AND AN AQUEOUS COMPOSITION CONTAINING A CATIONIC BINDER AKZO N.V. (NL) 1986-09-10 EP claimed
EP-0130680-A2 Cure to elastomers composition LOCTITE CORPORATION (US) 1985-01-09 EP claimed
US-4447582-A QUATERNIZATION, CROSSLINKING COPOLYMER RUBBER & CHEMICAL CORPORATION (US) 1984-05-08 US claimed
US-4439600-A Cure to elastomers compositions LOCTITE CORPORATION (US) 1984-03-27 US claimed
US-4378419-A Developer compositions containing telomeric quaternary salts XEROX CORPORATION (US) 1983-03-29 US claimed
US-4371601-A Positively charged developer compositions containing telomeric amines XEROX CORPORATION (US) 1983-02-01 US claimed
EP-0001954-B1 PROCESS FOR THE MANUFACTURE OF SAFETY GLASS AND PRODUCT OBTAINED ACCORDING TO THIS PROCESS COMMISSARIAT A L'ENERGIE ATOMIQUE Etablissement de Caractère Scientifique Technique et Industriel (FR) 1981-08-26 EP claimed
US-4258156-A Method of fabrication of a transparent laminated product COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 1981-03-24 US claimed